Purple Biotech Ltd. - American Depositary Shares (PPBT) Covered Calls
You can sell covered calls on Purple Biotech Ltd. - American Depositary Shares to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for PPBT (prices last updated Thu 4:16 PM ET):
| Purple Biotech Ltd. - American Depositary Shares (PPBT) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 3.45 | -0.16 | 3.42 | 3.66 | 205K | - | 0.0 |
| Covered Calls For Purple Biotech Ltd. - American Depositary Shares (PPBT) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Dec 20 | 2.5 | 1.00 | 2.66 | -6.0% | -1095.0% | |
| Jan 17 | 2.5 | 0.00 | 3.66 | -31.7% | -385.7% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs. It operates through two segments, Oncology, and Pain and Hypertension. The company's marketed products include Consensi, a fixed-dose combination of celecoxib and amlodipine besylate for the simultaneous treatment of osteoarthritis pain and hypertension in the United States, as well as in China and South Korea. Its oncology pipeline includes NT-219, a small molecule that is advancing as a monotherapy treatment of advanced solid tumors and in combination with cetuximab for the treatment of recurrent or metastatic squamous cell carcinoma of head and neck cancer in a planned phase 1/2 study; and CM-24, a monoclonal antibody blocking CEACAM1 that is being developed as a combination therapy with anti-PD1 checkpoint inhibitors for the treatment of non-small cell lung cancer and pancreatic cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. Purple Biotech Ltd. is headquartered in Tel Aviv, Israel.
| Top 10 Open Interest For Dec 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | EEM covered calls | 1. | QBTS covered calls | |
| 2. | SPY covered calls | 7. | IWM covered calls | 2. | CCL covered calls | |
| 3. | XLF covered calls | 8. | TLT covered calls | 3. | APLD covered calls | |
| 4. | QQQ covered calls | 9. | TSLA covered calls | 4. | QUBT covered calls | |
| 5. | FXI covered calls | 10. | KWEB covered calls | 5. | CLSK covered calls | |
Want more examples? PPBI Covered Calls | PPC Covered Calls
